Medicine guide
Ryaltris 25 μg / 600 μg
As listed in the register: Ryaltris 25 μg / 600 μg, Nasenspray, Suspension
25 μg + 600 μg ·
- Prescription only
- Breathing, airways, allergies and cough
- Active substance
- Mometasoni furoas + Olopatadinum
- Made by
- NOBEL Pharma Schweiz AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Allergische Rhinitis
From the official label · 2026-09-30 · Swissmedic
Details
| Made by | NOBEL Pharma Schweiz AG |
|---|---|
| Active substance | Mometasoni furoas + Olopatadinum |
| Used in | Breathing, airways, allergies and cough |
| Strength | 25 μg + 600 μg |
| Classification | R01AD59 · Breathing, airways, allergies and cough |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Ryaltris 25 μg / 600 μg, Nasenspray, Suspension |
| Packs | 56 Einzeldose(n) · 120 Einzeldose(n) · 240 Einzeldose(n) |
| Zulassungsnummer | 69672 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.